GLP-1 agonists reduce the risk of major cardiovascular events in older patients with type 2 diabetes...
GLP-1 agonists reduce the risk of major cardiovascular events in older patients with type 2 diabetes, and SGLT2 inhibitors prevent hospitalizations for acute heart failure.
About this item
Full title
GLP-1 agonists reduce the risk of major cardiovascular events in older patients with type 2 diabetes, and SGLT2 inhibitors prevent hospitalizations for acute heart failure.
Author / Creator
Publisher
Italy
Journal title
Recenti progressi in medicina, 2024-12, Vol.115 (12), p.604
Language
Italian
Formats
Publication information
Publisher
Italy
More information
Alternative Titles
Full title
GLP-1 agonists reduce the risk of major cardiovascular events in older patients with type 2 diabetes, and SGLT2 inhibitors prevent hospitalizations for acute heart failure.
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3146925600
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3146925600
Other Identifiers
ISSN
2038-1840
E-ISSN
2038-1840
DOI
10.1701/4392.43920
